Hu Ezegwui, Ikeako L C, Obiora-Okafor N C
Department of Obstetrics and Gynaecology, University of Nigeria Teaching Hospital, Enugu, Nigeria.
Niger J Med. 2012 Jul-Sep;21(3):266-71.
Contraception with Depot Medroxyprogesterone Acetate (Depo provera) is quite effective though not without side effects that may cause discontinuation amongst acceptors.
To evaluate client characteristics, their experiences and acceptability of Depo provera in Enugu and compare these with previous experiences elsewhere.
A review of the family planning records of new acceptors who used Depo provera between 1st January 2000 and 31st December 2005 at the family planning clinic of University of Nigeria Teaching Hospital, Ituku-Ozalla, Enugu.
Within the study period, 684 new clients accepted Depo provera, accounting for 21.4% of all new acceptors for various forms of contraception. The mean [+/- SD] age and parity of the 590 acceptors whose records were available were 34.40 +/- 6.03 years and 5.52 +/- 2.02 respectively. Seventy percent (70%) of the clients had 5 or more children. Most (51.6%) had primary education. Seventy percent of clients with 5 or more children wanted no more children while 30% of those gainfully employed use of Depo provera for child spacing. Fifty seven percent of clients accepted Depo provera within a year following confinement and 80.2% of them were breast feeding. Complications occurred in 54.2% of all acceptors, with menstrual abnormalities occurring in 94.4% of them. Secondary amenorrhoea was the commonest menstrual anomaly occurring in 81.1% of clients with menstrual problems. Discontinuation in use Depo provera was 51.5% after the first one year. Irregular injection schedules and default were common with a continuation rate of 25.6% at the end of they observation period. However, the complaints of side effects appeared to wane beyond the second year of use. Three accidental pregnancies (0.5%) occurred during the study period.
Depot medroxyprogesterone acetate injectable contraceptive is an effective method of contraception in Enugu. It is accepted mainly by clients that have completed their family and are breast feeding. Awareness of its side effects obviously enhances continuation.
醋酸甲羟孕酮长效避孕针（狄波 - 普维拉）避孕效果显著，但也存在一些副作用，可能导致使用者停药。
评估埃努古地区使用狄波 - 普维拉的客户特征、使用体验及接受程度，并与其他地区的既往经验进行比较。
回顾2000年1月1日至2005年12月31日期间在尼日利亚大学教学医院计划生育门诊（位于埃努古伊图库 - 奥扎拉）使用狄波 - 普维拉的新使用者的计划生育记录。
在研究期间，684名新客户接受了狄波 - 普维拉，占所有接受各种避孕方式新客户的21.4%。有记录的590名使用者的平均年龄（±标准差）和产次分别为34.40±6.03岁和5.52±2.02。70%的客户育有5个或更多子女。大多数（51.6%）接受过小学教育。70%育有5个或更多子女的客户不想再生育，而30%有工作的客户使用狄波 - 普维拉来间隔生育。57%的客户在产后一年内接受了狄波 - 普维拉，其中80.2%正在哺乳。54.2%的使用者出现并发症，其中94.4%出现月经异常。继发性闭经是最常见的月经异常，在有月经问题的客户中占81.1%。使用狄波 - 普维拉一年后的停药率为51.5%。注射时间不规律和未按时注射很常见，观察期结束时的持续使用率为25.6%。然而，副作用的抱怨在使用第二年之后似乎有所减少。研究期间发生了3例意外怀孕（0.5%）。
醋酸甲羟孕酮长效避孕针在埃努古是一种有效的避孕方法。主要被已完成生育且正在哺乳的客户所接受。对其副作用的了解显然有助于提高持续使用率。
Zotero 插件